Contatti:

cell: +39 329 0364389​

info@biomole.it

logo
logo

biomole@ALL RIGHT RESERVED 2019

cookie Policy | Privacy policy

201904151249411

FCGR2B-MAMAPCR real time

Quantification assay of FCGR2B gene polymorphism Ile232Thr          cod. BM-014

Principle of the test: Genotyping polymorphism Ile232Thr FCGR2B gene
Technology: MAMAPCR Real Time-PCR
Gene Target: FCGR2B
Specimen: DNA
Controls included: Yes
Results: Genotype
Number of tests: 25 tests BM-014
Kit storage: -20°C
Necessary equipment: 7500 Real Time PCR System
Status: Ready to use

FCGR2B-MAMAPCR real time  cod. BM-014

 

Quantification assay of FCGR2B gene polymorphism Ile232Thr

 

·      FCGR2B-MAMAPCR real time complete kit 25 tests BM-014

 

FcγRs are members of the immunoglobulin superfamily that bind to the Fc portion of IgG. FcγRs are found on the surface of natural killer cells, monocytes, neutrophils and mast cells, playing a critical role in immunity28. In humans, there are three main types of Fcγ receptors: high‐affinity FcγRI and low‐affinity FcγRII and FcγRIII. These low‐affinity receptors are important in both promoting and regulating the immune and inflammatory response to immune complexes and are encoded by FCGR genes, located in a genetically complex cluster on the long arm of chromosome 1 (1q23)29. Furthermore, several recent studies indicate that FCGR genetic variants may be useful in predicting response to monoclonal antibodies in cancer and other inflammatory‐autoimmune diseases, such as rituximab, trastuzumab and cetuximab30,31. Genetic variation of FCGR2B is associated with response to immunoglobuline (IVIg) treatment in patients with Kawasaki disease32 and immune thrombocytopenia (ITP)33.

We have established a novel analysis able to genotypes Ile232Thr FCGR2B polymorphism. This method is based on real-time PCR. A genetic test for upfront treatment with IVIg led to faster recovery and less severe bleeding events.. User friendly and complete, the FCGR2B gene polymorphism Ile232Thr PCR real time detection kit is suitable for any laboratory.

 

Reference

1.      Nimmerjahn, F., & Ravetch, J. V. (2008). Fcγ receptors as regulators of immune responses. Nature Reviews Immunology, 8(1), 34–47.

2.      Niederer, H. A., Willcocks, L. C., Rayner, T. F., Yang, W., Lau, Y. L., Williams, T. N., … Smith, K. G. (2010). Copy number, linkage disequilibrium and disease association in the FCGR locus. Human Molecular Genetics, 19(16), 3282–3294.

3.      Mellor, J. D., Brown, M. P., Irving, H. R., Zalcberg, J. R., & Dobrovic, A. (2013). A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer. Journal of Hematology and Oncology, 6, 1.

4.      White, A. L., Beers, S. A., & Cragg, M. S. (2014). FcγRIIB as a key determinant of agonistic antibody efficacy. Current Topics in Microbiology and Immunology, 382, 355–372.

5.      Shrestha S, Wiener HW, Olson AK, et al. Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease. J Allergy Clin Immunol 2011;128:677-80.

6.      Heitink-Pollé KMJ, Uiterwaal CSPM, Porcelijn L, Tamminga RYJ, Smiers FJ, van Woerden NL, Wesseling J, Vidarsson G, Laarhoven AG, de Haas M, Bruin MCA; TIKI Investigators. Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial. Blood. 2018 Aug 30;132(9):883-891. doi: 10.1182/blood-2018-02-830844.